Habib Insurance Company Limited (PSX:HICL)
13.09
+0.30 (2.35%)
At close: Aug 1, 2025
CTI BioPharma Balance Sheet
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Investments in Debt Securities | 250 | 250 | 250 | 753.55 | 130.22 | 329.94 | Upgrade |
Investments in Equity & Preferred Securities | 2,308 | 2,009 | 1,253 | 821.12 | 1,210 | 1,022 | Upgrade |
Total Investments | 2,558 | 2,259 | 1,503 | 1,575 | 1,341 | 1,352 | Upgrade |
Cash & Equivalents | 24.93 | 475.04 | 661.86 | 395.78 | 96.81 | 194.28 | Upgrade |
Reinsurance Recoverable | 1,459 | 1,428 | 1,411 | 908.89 | 1,117 | 1,068 | Upgrade |
Other Receivables | 833.8 | 947.3 | 807 | 817.49 | 823.11 | 620.93 | Upgrade |
Property, Plant & Equipment | 99.27 | 99.41 | 114.02 | 56.1 | 68.89 | 185.18 | Upgrade |
Other Intangible Assets | 12.61 | 13.36 | 0.24 | 0.45 | 0.67 | 2.19 | Upgrade |
Other Current Assets | 506.98 | 735.07 | 715.34 | 558.39 | 512.53 | 488.66 | Upgrade |
Long-Term Deferred Charges | 208.58 | 250.92 | 217.07 | 169.58 | 145.64 | 106.23 | Upgrade |
Other Long-Term Assets | 458.44 | 276.09 | 64.67 | 62.3 | 88.02 | - | Upgrade |
Total Assets | 6,162 | 6,485 | 5,494 | 4,544 | 4,194 | 4,018 | Upgrade |
Accrued Expenses | 191.9 | 323.78 | 257.07 | 189.04 | 198.23 | 113.26 | Upgrade |
Insurance & Annuity Liabilities | 370.55 | 383.5 | 373.08 | 117.21 | 180.38 | 114.03 | Upgrade |
Unpaid Claims | 1,109 | 1,044 | 1,055 | 959.57 | 786.59 | 819.12 | Upgrade |
Unearned Premiums | 1,451 | 1,810 | 1,582 | 1,419 | 1,179 | 959.63 | Upgrade |
Reinsurance Payable | 328.51 | 381.72 | 337.47 | 397.31 | 243.03 | 233.49 | Upgrade |
Current Portion of Leases | - | 16.38 | 19.36 | 14.54 | 11.99 | 24.67 | Upgrade |
Short-Term Debt | 154.13 | - | - | - | - | - | Upgrade |
Current Income Taxes Payable | - | - | - | - | - | 2.25 | Upgrade |
Long-Term Leases | 25.82 | 9.38 | 21.4 | 16.37 | 25.54 | 112.97 | Upgrade |
Long-Term Deferred Tax Liabilities | 271.27 | 296.89 | 142.07 | 17.29 | 82.02 | 124.13 | Upgrade |
Other Current Liabilities | 70.15 | 69.65 | 69.39 | 83.54 | 62.81 | 63.25 | Upgrade |
Other Long-Term Liabilities | 9.27 | 10.5 | 40.22 | 30.87 | 37.87 | 31.54 | Upgrade |
Total Liabilities | 4,068 | 4,429 | 3,991 | 3,375 | 2,939 | 2,718 | Upgrade |
Common Stock | 619.37 | 619.37 | 619.37 | 619.37 | 619.37 | 619.37 | Upgrade |
Retained Earnings | 777.82 | 684.35 | 499.13 | 448.09 | 406.77 | 356.01 | Upgrade |
Comprehensive Income & Other | 697.55 | 751.7 | 384.95 | 100.84 | 228.93 | 324.86 | Upgrade |
Shareholders' Equity | 2,095 | 2,055 | 1,503 | 1,168 | 1,255 | 1,300 | Upgrade |
Total Liabilities & Equity | 6,162 | 6,485 | 5,494 | 4,544 | 4,194 | 4,018 | Upgrade |
Filing Date Shares Outstanding | 123.87 | 123.87 | 123.87 | 123.87 | 123.87 | 123.87 | Upgrade |
Total Common Shares Outstanding | 123.87 | 123.87 | 123.87 | 123.87 | 123.87 | 123.87 | Upgrade |
Total Debt | 179.95 | 25.76 | 40.77 | 30.91 | 37.53 | 137.64 | Upgrade |
Net Cash (Debt) | -155.03 | 449.28 | 621.1 | 364.87 | 59.28 | 56.63 | Upgrade |
Net Cash Growth | - | -27.66% | 70.23% | 515.46% | 4.68% | - | Upgrade |
Net Cash Per Share | -1.25 | 3.63 | 5.01 | 2.95 | 0.48 | 0.46 | Upgrade |
Book Value Per Share | 16.91 | 16.59 | 12.14 | 9.43 | 10.13 | 10.50 | Upgrade |
Tangible Book Value | 2,082 | 2,042 | 1,503 | 1,168 | 1,254 | 1,298 | Upgrade |
Tangible Book Value Per Share | 16.81 | 16.48 | 12.13 | 9.43 | 10.13 | 10.48 | Upgrade |
Machinery | - | 155.7 | 141.93 | 84.01 | 79.57 | 206.11 | Upgrade |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.